DrugPatentWatch Database Preview
Alemtuzumab - Biologic Drug Details
Summary for alemtuzumab
| Tradenames: | 2 |
| Patents: | 301 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for alemtuzumab |
Pharmacology for alemtuzumab
| Mechanism of Action | CD52-directed Antibody Interactions |
US Patents for alemtuzumab
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genzyme | CAMPATH | alemtuzumab | VIAL; INTRAVENOUS | 103948 | 001 | 2001-05-07 | ➤ Try a Free Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | ➤ Try a Free Trial | RX | Orphan | search |
| Genzyme | CAMPATH | alemtuzumab | VIAL; INTRAVENOUS | 103948 | 001 | 2001-05-07 | ➤ Try a Free Trial | IBC Pharmaceuticals, Inc. (Morris Plains, NJ) | ➤ Try a Free Trial | RX | Orphan | search |
| Genzyme | CAMPATH | alemtuzumab | VIAL; INTRAVENOUS | 103948 | 001 | 2001-05-07 | ➤ Try a Free Trial | University of Georgia Research Foundation, Inc. (Athens, GA) | ➤ Try a Free Trial | RX | Orphan | search |
| Genzyme | CAMPATH | alemtuzumab | VIAL; INTRAVENOUS | 103948 | 001 | 2001-05-07 | ➤ Try a Free Trial | AbbVie Stemcentrx LLC (North Chicago, IL) | ➤ Try a Free Trial | RX | Orphan | search |
| Genzyme | CAMPATH | alemtuzumab | VIAL; INTRAVENOUS | 103948 | 001 | 2001-05-07 | ➤ Try a Free Trial | University of the Sciences of Philadelphia (Philadelphia, PA) | ➤ Try a Free Trial | RX | Orphan | search |
| Genzyme | CAMPATH | alemtuzumab | VIAL; INTRAVENOUS | 103948 | 001 | 2001-05-07 | ➤ Try a Free Trial | INNATE PHARMA S.A. (Marseilles, FR) | ➤ Try a Free Trial | RX | Orphan | search |
| Genzyme | CAMPATH | alemtuzumab | VIAL; INTRAVENOUS | 103948 | 001 | 2001-05-07 | ➤ Try a Free Trial | UNIVERSITY OF WYOMING (Laramie, WY) | ➤ Try a Free Trial | RX | Orphan | search |
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
International Patents for alemtuzumab
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Eurasian Patent Organization | 009383 | ➤ Try a Free Trial |
| Hong Kong | 1089654 | ➤ Try a Free Trial |
| Israel | 195580 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 2010065078 | ➤ Try a Free Trial |
| Taiwan | 201609657 | ➤ Try a Free Trial |
| European Patent Office | 1961416 | ➤ Try a Free Trial |
| Austria | 494287 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for alemtuzumab
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 138 | Luxembourg | ➤ Try a Free Trial | PRODUCT NAME: RITUXIMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20140326 |
| C00065 | Luxembourg | ➤ Try a Free Trial | PRODUCT NAME: CLADRIBINE; AUTHORISATION NUMBER AND DATE: EU/1/17/1212 20170824 |
| 2018502 | Lithuania | ➤ Try a Free Trial | PRODUCT NAME: KLADRIBINAS; REGISTRATION NO/DATE: EU1/17/1212/001-006 20170822 |
| 0160019 00200 | Estonia | ➤ Try a Free Trial | PRODUCT NAME: ALEMTUZUMAB;REG NO/DATE: EU/1/13/869 16.09.2013 |
| 2015031 | Lithuania | ➤ Try a Free Trial | PRODUCT NAME: TRASTUZUMABAS IR REKOMBINANTINE ZMOGAUS HIALURONIDAZE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826 |
| 3 5012-2016 | Slovakia | ➤ Try a Free Trial | PRODUCT NAME: ALEMTUZUMAB; REGISTRATION NO/DATE: EU/1/13/869 20130916 |
| 16/024 | Ireland | ➤ Try a Free Trial | PRODUCT NAME: ALEMTUZUMAB; REGISTRATION NO/DATE: EU/1/13/869 20130912 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
